No Data
LifeMD, Inc.'s (NASDAQ:LFMD) Market Cap Dropped US$62m Last Week; Individual Investors Who Hold 43% Were Hit as Were Institutions
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating
LifeMD to Participate in Three Investor Conferences During November
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
LifeMD Analyst Ratings
Strong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite Challenges